Market Cap

EBOS Group Limited Market Capitalization:

A$5.66 Billion

AUD as of July 1, 2024

US$3.77 Billion

business EBOS Group Limited Company Profile

EBOS Group Limited Main Stock Listing

ASX: EBO

Market Capitalization History of EBOS Group Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Distribution
Company Market Cap (USD)
McKesson Corporation $75.67 B
Cencora, Inc. $43.82 B
Cardinal Health, Inc. $23.31 B
Shanghai Pharmaceuticals Holding Co. Ltd $8.79 B
Sinopharm Group Co. Ltd $8.37 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of EBOS Group Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$6.53 B -18.96%
Jan. 1, 2023 A$8.06 B 14.19%
Jan. 1, 2022 A$7.06 B 40.48%
Jan. 31, 2021 A$5.02 B -3.26%
Jan. 1, 2021 A$5.19 B 20.32%
Jan. 31, 2020 A$4.32 B -3.44%
Jan. 1, 2020 A$4.47 B 12.37%
Jan. 31, 2019 A$3.98 B -1.82%
Jan. 1, 2019 A$4.05 B 26.23%
Jan. 31, 2018 A$3.21 B -2.19%
Jan. 1, 2018 A$3.28 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

EBOS Group Limited Categories

Australia languages Healthcare languages Medical Distribution
Australia Healthcare Australia Medical Distribution

Stocks & Indices

EBOS Group Limited has the following listings and related stock indices.


Stock: ASX: EBO

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.